AGMB

AgomAb Therapeutics NV American Depositary Shares

Nasdaq · usd

$8.87-0.18 (-1.99%)

As of 2:20:35 PM EDT on Oct 26, 2026 · 15-minute delayed

AgomAb Therapeutics NV American Depositary Shares (AGMB) trades at $8.87 (-1.99%) as of 2:20:35 PM EDT on Oct 26, 2026, -15.79% over the past month. Market cap is $445.69M, with 7.1 days to cover in short interest.

Stock performance

How AgomAb Therapeutics NV American Depositary Shares (AGMB) stock has performed from one day to one year, with its 52-week range.

-2.42%

-$0.22 over 1D

1D: -2.21%
1W: +7.53%
1M: -15.79%
YTD: -39.59%
1Y: -39.59%
52-wk range: $7.92 – $17.82

Key statistics

Today's trading snapshot for AGMB: day range, open, previous close, volume and market cap.

Day range: $8.69 – $9.33
Open: $9.10
Prev close: $9.05
Volume: 47.82K
Market cap: $445.69M
Shares out: 49.25M

Insider buying and selling

In the 12 months to Oct 26, 2026, 3 AGMB insiders reported open-market purchases of $400.0K across 5 filings; no open-market sales were filed.

Who traded AGMB, and when

Purchase

AGMB daily closelast $8.85

David R. Epstein · Director

$219.7K bought

Tim Jasper Knotnerus · Chief Executive Officer

$94.4K bought

Pierre Thadee Victor Kemula · Chief Financial Officer

$85.9K bought

One row per insider; marks sit at the SEC filing date, sized by dollar value.

See who traded and when →

AGMB short interest

How heavily AGMB is shorted: shares short, days to cover and average daily volume.

Days to cover: 7.1
Short interest: 1M
Avg volume: 140.68K

As of Sep 30, 2026 · reported to FINRA twice monthly.

AGMB news

The latest news and headlines about AgomAb Therapeutics NV American Depositary Shares (AGMB).

Agomab Announces Results of Annual General Meeting
neutralGlobeNewswire Inc.· May 27, 2026
Agomab Reports Full Year 2025 Financial Results and Confirms 2026 Outlook
positiveGlobeNewswire Inc.· Apr 23, 2026
Agomab Receives U.S. Patent for AGMB-447, its Inhaled Lung-restricted Small Molecule Inhibitor of ALK5 in Development for the Treatment of Idiopathic Pulmonary Fibrosis
positiveGlobeNewswire Inc.· Mar 26, 2026
Agomab Announces Closing of Initial Public Offering
positiveBenzinga· Feb 9, 2026

Frequently asked questions

What is the AgomAb Therapeutics NV American Depositary Shares (AGMB) stock price today?

AgomAb Therapeutics NV American Depositary Shares (AGMB) is trading at $8.87 (-1.99% on the day) as of 2:20:35 PM EDT on Oct 26, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.

What is AgomAb Therapeutics NV American Depositary Shares?

AgomAb Therapeutics NV is a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies for immunology and inflammatory diseases, with an initial focus on chronic fibrotic indications with high unmet medical need.

What is the short interest in AGMB?

As of Sep 30, 2026, AGMB has 1M shares short and 7.1 days to cover.

What exchange is AGMB listed on?

AgomAb Therapeutics NV American Depositary Shares (AGMB) trades on Nasdaq in USD.

Build with AI

Build an analysis of AGMB with your agent

Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.

Claude ChatGPT

Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a AGMB analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.

Live market data from the Massive API and MCP.Get a free API key

Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.